Invitae offers broad reproductive and family testing options, powered by Good Start Genetics and CombiMatrix. Tests include:
GeneVuTM provides actionable information about the risks of passing on a genetic condition to a child, providing next steps for a couple's reproductive journey.
Preimplantation genetic screening (PGS)
EmbryVuTM screens embryos for chromosomal problems by next-generation sequencing to optimize IVF outcomes by identifying healthy embryos for transfer.
CombiSNPTM Array for pregnancy loss determines whether a miscarriage, fetal demise, or stillbirth was caused by a fetal chromosome abnormality. Microarray testing is superior to traditional methods of testing, such as karyotyping.
Prenatal diagnosis by chromosomal microarray
CombiSNPTM chromosomal microarray analysis (CMA) is a high-resolution chromosomal test that can identify disorders of the chromosomes caused by a variety of abnormalities.
Prenatal diagnosis by karyotyping
Karyotyping evaluates the number and structure of the fetal chromosomes and is offered for patients who do not wish to undergo more sensitive microarray testing, or who are at an increased risk a specific numeric chromosomal abnormality.
Prenatal adjunct testing
In situations suggesting a significantly increased risk of a numeric chromosome abnormality of chromosome 13, 18, 21, X or Y, CombiFISHTM provides a quick (<48 hour) evaluation of these specific chromosomes while awaiting definitive results from a fetal microarray or karyotype.
Karyotyping evaluates the number and structure of chromosomes, enabling the identification of underlying issues that can lead to miscarriage or infertility.
Preimplantation genetic diagnosis (PGD)
CombiPGDTM identifies single-gene disorders in embryos for couples who have an increased risk of having a child with a specific genetic disorder or chromosomal abnormality based on their own genetic status.
Learn more on our reproductive and family health webpage.